CTLA4 and neoplasm: In a murine model of PCa, a novel dual therapy approach combining primary tumor destruction using irreversible electroporation, followed by anti-CTLA-4 treatment not only confirmed the establishment of TRM cells but also demonstrated their pivotal role in conferring protection against subsequent tumor challenges.